JAGSONPAL PHARMACEUTICALS
Back to Balance Sheet
|
JAGSONPAL PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹2.07 Cr | ₹2.16 Cr | ₹3.24 Cr | ₹1.86 Cr | ₹3.09 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of JAGSONPAL PHARMACEUTICALS ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹2.07 Cr |
Mar2023 | ₹2.16 Cr |
Mar2022 | ₹3.24 Cr |
Mar2021 | ₹1.86 Cr |
Mar2020 | ₹3.09 Cr |
How is Deferred Tax Assets / Liabilities of JAGSONPAL PHARMACEUTICALS Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹2.07 Cr | -4.16 | |
Mar2023 | ₹2.16 Cr | -33.20 | |
Mar2022 | ₹3.24 Cr | 74.18 | |
Mar2021 | ₹1.86 Cr | -39.88 | |
Mar2020 | ₹3.09 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of JAGSONPAL PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JAGSONPAL PHARMACEUTICALS | ₹1,447.5 Cr | 8.2% | -20.7% | 43% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹428,557.0 Cr | 2.3% | -0.8% | 32.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,994.0 Cr | 3.2% | 1.1% | 51.5% | Stock Analytics | |
CIPLA | ₹116,494.0 Cr | 0.3% | -2% | 10% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,297.0 Cr | -1.8% | 2.7% | 12.7% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,035.0 Cr | 2% | 1.5% | 38% | Stock Analytics |
JAGSONPAL PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JAGSONPAL PHARMACEUTICALS | 8.2% |
-20.7% |
43% |
SENSEX | -1% |
-5% |
5.6% |
You may also like the below Video Courses